LKT Labs

Biochemicals for Life Science Research

Medroxyprogesterone 17-Acetate

Medroxyprogesterone 17-Acetate

Product ID M1613
Cas No. 71-58-9
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $57.10 In stock
1 g $95.20 In stock
5 g $365.90 In stock
Bulk Quote

Quicklinks

Description

Medroxyprogesterone 17-acetate (MPA) is a synthetic steroid that activates progesterone, androgen, and glucocorticoid receptors. MPA exhibits contraceptive and anticancer activities and is also used in hormone replacement therapy, endometriosis, and dysmenorrhea. MPA decreases levels of adrenocorticotropic hormone (ACTH), cortisol, and other hormones; it also inhibits 3α-hydroxysteroid dehydrogenase. This compound is used clinically to treat breast cancer and inhibits the proliferation and growth of breast cancer cells and tumors in various models.

Product Info

Cas No.

71-58-9
Purity

≥98%
Formula

C24H34O4
Formula Wt.

386.52
Chemical Name

17-α-Acetoxy-6α-methylprogesterone
IUPAC Name

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9, 11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Synonym

MAP, Clinovir, Depo-Provera, Farlutal, Nidaxin, Oragest, Prodasone, Provera, Veramix
Melting Point

207-209°C
Solubility

Soluble in chloroform or acetone.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

M1613 MSDS PDF
Info Sheet

M1613 Info Sheet PDF

References

Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2008 Sep-Oct;61(1-2):171-80. PMID: 19434889.

Meyer L, Venard C, Schaeffer V, et al. The biological activity of 3alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury. Neurobiol Dis. 2008 Apr;30(1):30-41. PMID: 18291663.

Poulin R, Baker D, Poirier D, et al. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat. 1989 Mar;13(2):161-72. PMID: 2525057.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D3329

    7,8-Dihydroxyflavone Hydrate

    TrkB agonist.
    ≥99%
  • C3578

    L-Citrulline

    Byproduct of L-arginine metabolism found in waterm...
    ≥98%
  • P0370

    Paromomycin Sulfate

    Aminoglycoside; protein translation inhibitor, cat...
    ≥98%
  • D3303

    Diacerein

    Anthraquinone; IL-1β inhibitor.
    ≥98%
  • L9701

    LY-450139

    GHS-R1a agonist, γ-secretase inhibitor.
    ≥98%
  • A2401

    AG-18

    EGFR and PDGFR inhibitor
    ≥98%
  • T0110

    Taxane Standard Mixture

    Mixture of taxanes.
    ≥98%
  • A5276

    Angiotensin I, human

    Endogenous peptide, cleavage product of angiotensi...
    ≥98%
  • A9914

    AZD-8055

    mTOR inhibitor.
    ≥98%
  • Z160021

    Zearalanone

    Mycotoxin.
    ≥97%
  • P1767

    Peptide F, cow

    Endogenous pro-enkephalin peptide.
    ≥95%
  • C4417

    Clemizole

    TRPC5 activator, NS4B and histamine H1 inhibitor.
    ≥98%
  • A7668

    Atracurium Besylate

    Non-depolarizing NMJ blocker; AChR antagonist.
    ≥95%
  • M4102

    MK-1775

    Wee1 inhibitor.
    ≥98%
  • K0036

    Kahweol Linoleate

    Diterpene found in coffee beans.
    ≥98%
  • S6134

    Spinorphin, cow

    Endogenous heptapeptide; P2X3 and N-formylpeptide ...
    ≥95%
  • K1653

    Kendomycin

    Macrolide; ET antagonist, proteasome inhibitor.
    ≥98%
  • S0133

    Saikosaponin C

    Triterpene saponin found in Bupleurum.
    ≥98%
  • L8008

    D-Luciferin, firefly, Free Acid

    Heterocyclic light-emitting compound, natural liga...
    ≥98%
  • D3420

    4-(3,4-Difluorobenzo)curcumin

    Curcumin derivative.
    ≥95%